Dr. Callewaert is Professor Emeritus of Chemistry and was Founding Director of Oakland University’s Center for Biomedical Research. During his 35 year academic career, he characterized human Natural Killer lymphocytes, and authored Chemistry and Biochemistry textbooks. Dr. Callewaert also founded four biotechnology companies, including Oxford Biomedical Research. In 1995, he founded Oxford Laboratories which developed the TgAA test for early diagnosis of canine autoimmune thyroiditis. For the past 10 years his research has focused on the development and commercialization of novel methods to measure oxidative stress and inflammation.
IVC Journal is a division of Redstone Media Group. Innovation is the key to veterinarians staying competitive and being able to provide their clients with the absolute best care possible. IVC Journal delivers the most up to date and compelling information available by bridging the gap between the traditional worlds of allopathic and integrative veterinary care.